Top Canadian Business Events in March 2022
Find the top business events and webinars this March from various Canadian business leaders relating to grants, tax credits, improving leadership, and increasing productivity.
Airzone One Ltd. vs. Her Majesty the Queen: New Court Case Expands SR&ED Eligibility
The Airzone One Ltd. vs. Her Majesty the Queen court case has changed the future of SR&ED eligibility criteria.
British Columbia’s 2022 Budget: Business Funding Implications
Explore the impacts of BC’s 2022 Budget on the Canadian BC business grants landscape.
Innovative Solutions Canada (ISC) Announces New Challenge To Help Fight Wildfires
Canadian innovators can access grants and procurement contracts to research and develop solutions for government COVID-19 challenges. Browse ISC’s current challenges.
Ontario Together Fund (OTF) Awards $2.9 Million Towards Solving COVID-19 Challenges
The Ontario Together Fund (OTF) has provided $2.9 million in grant funding towards five businesses with projects that address COVID-19 challenges that are currently being faced.
Energy Innovation Program: Clean Fuels and Industrial Fuel Switching
The Energy Innovation Program provides funding for Canadian cleantech businesses with R&D projects that help create clean energy.
Fall 2021 Ontario Economic Outlook and Fiscal Review
The Fall 2021 Ontario Economic Outlook & Fiscal Review provides an overview of where the provincial government plans to spend their investment money to grow its workforce and economy.
Natural Products Canada’s Proof of Concept Program
NPC’s Proof of Concept Program helps SMEs and academic institutions accelerate natural products at TRLs ranging from four-nine to market.
Securing Canada’s Biosciences Sector
Canada’s Biomanufacturing and Life Sciences Strategy (CBLSS) aims to secure the nation’s biomanufacturing and life sciences sector.
Ontario Research Getting Boost from the Research Excellence Program
The Ontario Research Fund – Research Excellence (ORF-RE) supports research institutions by funding major project costs for promising studies.